Prophylactic cranial irradiation in non-small cell lung cancer

被引：3

作者：

Mazeron, R. ^{[1
]}

Le Pechoux, C. ^{[1
]}

Bruna, A. ^{[1
]}

Amarouch, A. ^{[1
]}

Bretel, J. -J. ^{[1
]}

Ferreira, I. ^{[2
]}

机构：

[1] Inst Gustave Roussy, Dept Radiotherapie, F-94800 Villejuif, France

[2] Inst Gustave Roussy, Dept Radiophys, F-94800 Villejuif, France

来源：

CANCER RADIOTHERAPIE | 2007年 / 11卷 / 1-2期

关键词：

non small cell lung cancer; brain metastases; prophylactic cranial irradiation;

D O I：

10.1016/j.canrad.2006.07.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prophylactic cranial irradiation (PCI) has become part of the standard treatment in patients with small cell lung cancer (SCLC) in complete remission. Not only does it decrease the risk of brain recurrence by almost 50%, it has a significant positive effect on survival (5.4 percent increase at 3 years). As the prognosis of patients with locally advanced non-small cell lung cancer (NSCLC) has improved with combined modality treatment, brain metastases have also become an important cause of failure (10 to 30%, approaching 50% in certain studies as in SCLC). Survival after treatment of brain metastases is poor and impact on quality of life of patients is important. As in SCLC, 4 randomised evaluating PCI in NSCLC have been carried out in the seventies and early eighties. If 3 out of 4 trials have shown a significant decrease of brain metastases, none of them demonstrated any impact on survival. Thus PCI cannot be recommended as standard treatment in NSCLC, however new trials would be needed. (c) 2006 Elsevier Masson SAS.

引用

页码：84 / 91

页数：8

共 60 条

[1] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805 [J].

ALBAIN, KS ;

RUSCH, VW ;

CROWLEY, JJ ;

RICE, TW ;

TURRISI, AT ;

WEICK, JK ;

LONCHYNA, VA ;

PRESANT, CA ;

MCKENNA, RJ ;

GANDARA, DR ;

FOSMIRE, H ;

TAYLOR, SA ;

STELZER, KJ ;

BEASLEY, KR ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1880-1892

[2]

ALBERTI W, 1995, BRIT MED J, V311, P899

[3]

Andre F, 2001, CANCER, V91, P2394, DOI 10.1002/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.3.CO

[4]

2-Y

[5]

[Anonymous], 1998, CANC THER

[6] PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION [J].

ARRIAGADA, R ;

LECHEVALIER, T ;

BORIE, F ;

RIVIERE, A ;

CHOMY, P ;

MONNET, I ;

TARDIVON, A ;

VIADER, F ;

TARAYRE, M ;

BENHAMOU, S .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :183-190

[7] Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].

Aupérin, A ;

Arriagada, R ;

Pignon, JP ;

Le Péchoux, C ;

Gregor, A ;

Stephens, RJ ;

Kristjansen, PEG ;

Johnson, BE ;

Ueoka, H ;

Wagner, H ;

Aisner, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484

[8] Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma [J].

Bajard, A ;

Westeel, V ;

Dubiez, A ;

Jacoulet, P ;

Pernet, D ;

Dalphin, JC ;

Depierre, A .

LUNG CANCER, 2004, 45 (03) :317-323

[9]

Budach W, 2003, P AN M AM SOC CLIN, V22, P637

[10] Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? [J].

Carolan, H ;

Sun, AY ;

Bezjak, A ;

Yi, QL ;

Payne, D ;

Kane, G ;

Waldron, J ;

Leighl, N ;

Feld, R ;

Burkes, R ;

Keshavjee, S ;

Shepherd, F .

LUNG CANCER, 2005, 49 (01) :109-115

← 1 2 3 4 5 6 →